ClinicalTrials.gov
ClinicalTrials.gov Menu

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00758199
Recruitment Status : Completed
First Posted : September 25, 2008
Last Update Posted : March 15, 2012
Sponsor:
Information provided by (Responsible Party):
Bp Consulting, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2010
  Actual Study Completion Date : January 2010